# Ophtapharm AG, Winterthur, Switzerland – FDA Inspections

Source: https://www.keypedia.com/companies/ophtapharm-ag/bf7065a3-51c2-4dd4-bcac-c2e0ab295ec4

> Inspection records and compliance data for Ophtapharm AG in Winterthur. 6 FDA inspections on record, 1 Form 483, last inspected July 07, 2023.

---

## Details

- Name: Ophtapharm AG
- FEI Number: 3005531475
- Facility Type: Manufacture of finished drug product
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK
- Address Line 1: Technoparkstrasse 7
- City: Winterthur
- Country Name: Switzerland
- Address: Technoparkstrasse 7, Winterthur, Switzerland
- Country: Switzerland

## Related Documents

- FDA Inspection 1245095 - Ophtapharm AG - 2023-07-07 — source: FDA, date: July 7, 2023
- [483 - Ophtapharm AG - 2020-02-28](https://www.keypedia.com/records/483/ophtapharm-ag/10f6230a-227e-4b14-852b-d8807f88e27b) — source: FDA, date: February 28, 2020
- FDA Inspection 1119623 - Ophtapharm AG - 2020-02-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 28, 2020
- [FDA Inspection 1119623 - Ophtapharm AG - 2020-02-28](https://www.keypedia.com/records/fda_inspections/ophtapharm-ag/f3ead780-b0ba-4dff-983c-b5833be32fd4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 28, 2020
- [483 - Ophtapharm AG - 2017-12-12](https://www.keypedia.com/records/483/ophtapharm-ag/abd01715-ac17-4651-8e5e-633204787534) — source: FDA, date: December 12, 2017
- [FDA Inspection 1034597 - Ophtapharm AG - 2017-12-12](https://www.keypedia.com/records/fda_inspections/ophtapharm-ag/af1221b4-46e5-4a05-a6ae-042a56390d1f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 12, 2017
- [FDA Inspection 980040 - Ophtapharm AG - 2016-05-25](https://www.keypedia.com/records/fda_inspections/ophtapharm-ag/8fa3ce26-3173-44f2-9829-9fb6c1d9d09e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 25, 2016
- FDA Inspection 980040 - Ophtapharm AG - 2016-05-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 25, 2016
- [FDA Inspection 878584 - Ophtapharm AG - 2014-03-28](https://www.keypedia.com/records/fda_inspections/ophtapharm-ag/b26e0f23-0f90-43c1-bb44-4cc19d9a9b53) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 28, 2014
- FDA Inspection 754443 - Ophtapharm AG - 2011-11-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2011

## Related Companies

- [Haupt Pharma Wuelfing GmbH](https://www.keypedia.com/companies/haupt-pharma-wuelfing-gmbh/34339ef4-fb2f-4297-ae5d-191a6adb86b0)
- [Bushu Pharmaceuticals Ltd.](https://www.keypedia.com/companies/bushu-pharmaceuticals-ltd/f3ccab51-b6fa-4873-b2de-61ba32d7967e)
- [Catalent CTS, LLC](https://www.keypedia.com/companies/catalent-cts-llc/db17ec22-68a4-42be-86e9-4c1410a493a8)
- [DPT Laboratories, Ltd](https://www.keypedia.com/companies/dpt-laboratories-ltd/0a6b4d0a-ad7e-4f4f-ab10-34e0ef9913d4)
- [Kavis Pharma LLC](https://www.keypedia.com/companies/kavis-pharma-llc/453e3985-3964-40f5-aeaf-89cd2cb6f954)
- [Corden Pharma S.p.A.](https://www.keypedia.com/companies/corden-pharma-spa/9ebac113-b666-42f4-bce9-0183154975f3)
- [AbbVie Inc.](https://www.keypedia.com/companies/abbvie-inc/e9d2de86-ad64-4278-8fb3-a8cd7909719e)
- [Afton Scientific, LLC](https://www.keypedia.com/companies/afton-scientific-llc/e5ec92fc-2eb5-4366-8d78-fd597c977fe8)
- [Fareva Amboise](https://www.keypedia.com/companies/fareva-amboise/4d8ebbcc-2e13-4584-b144-63aa8191bc92)
- [American Regent, Inc.](https://www.keypedia.com/companies/american-regent-inc/a73360d0-4ea2-40a4-aa12-221cece9173f)

## Related Officers

- [Compliance Officer](https://www.keypedia.com/people/yasamin-ameri/73021772-c960-4c65-aa30-cb490866ee58)
- [Russell J. Glapion](https://www.keypedia.com/people/russell-j-glapion/54dd6274-563a-44fe-8016-2ebd700be7a0)
